{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:49:56Z","timestamp":1786988996701,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euo.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:35:26Z","timestamp":1738262126000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography"],"prefix":"10.1016","volume":"9","author":[{"given":"Giorgio","family":"Gandaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai A.","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gomez Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo F.W.","family":"Soeterik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Darr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Zattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Robesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Moreno","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mottrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.01.004_b0005","unstructured":"Cornford P, Tilki D, Van Den Bergh RCN, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG-guidelines on prostate cancer. 2024. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/ EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2024_2024-04-09-132035_ypmy_2024-04-16-122605_lqpk.pdf."},{"key":"10.1016\/j.euo.2025.01.004_b0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0020","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1200\/JCO.21.02800","article-title":"Adjuvant versus early salvage radiation therapy after radical prostatectomy for pN1 prostate cancer and the risk of death","volume":"40","author":"Tilki","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0025","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/JU.0000000000002855","article-title":"Not all adverse pathology features are equal: identifying optimal candidates for adjuvant radiotherapy among patients with adverse pathology at radical prostatectomy","volume":"208","author":"Mazzone","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","article-title":"Impact of pelvic lymph node dissection and its extent on perioperative morbidity in patients undergoing radical prostatectomy for prostate cancer: a comprehensive systematic review and meta-analysis","volume":"4","author":"Cacciamani","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","article-title":"Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euo.2021.08.001","volume":"5","author":"Stabile","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0055","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective , randomised , multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2025.01.004_b0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2021.05.006","article-title":"External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study","volume":"80","author":"Meijer","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.euo.2023.03.010","article-title":"Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission","volume":"6","author":"Vis","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.euo.2023.05.003","volume":"6","author":"Gandaglia","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2020.06.023","article-title":"Focus on the quality of prostate multiparametric magnetic resonance imaging: synopsis of the ESUR\/ESUI recommendations on quality assessment and interpretation of images and radiologists\u2019 training","volume":"78","author":"de Rooij","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0085","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3390\/diagnostics11112068","article-title":"Preliminary results of an ongoing prospective clinical trial on the use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET\/MRI in staging of high-risk prostate cancer patients","volume":"11","author":"Mapelli","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.euo.2025.01.004_b0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bju.14066","article-title":"Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer","volume":"121","author":"Gandaglia","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.01.004_b0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12874-022-01674-x","article-title":"Accommodating heterogeneous missing data patterns for prostate cancer risk prediction","volume":"22","author":"Neumair","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.euo.2025.01.004_b0100","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bju.13540","article-title":"Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer","volume":"119","author":"van Leeuwen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.01.004_b0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"Gandaglia","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bju.13540","article-title":"Prospective evaluation of 68Gallium\u2010prostate\u2010specific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer","volume":"119","author":"van Leeuwen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.01.004_b0120","doi-asserted-by":"crossref","unstructured":"Touijer KA, Vertosick EA, Sjoberg DD, et al. Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2024.10.006.","DOI":"10.1016\/j.eururo.2024.10.006"},{"key":"10.1016\/j.euo.2025.01.004_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","article-title":"Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy","volume":"65","author":"Touijer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2008.09.043","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"issue":"Suppl 2","key":"10.1016\/j.euo.2025.01.004_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bju.16482","article-title":"Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics","volume":"134","author":"Roberts","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.01.004_b0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bju.15762","article-title":"Event\u2010free survival after radical prostatectomy according to prostate\u2010specific membrane antigen\u2010positron emission tomography and European Association of Urology biochemical recurrence risk groups","volume":"130","author":"Roberts","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.01.004_b0145","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00345-017-2079-4","article-title":"Long \u2011 term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment","volume":"35","author":"Mandel","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.01.004_b0150","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2013.54.7893","article-title":"Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer","volume":"32","author":"Abdollah","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.euo.2023.07.001","article-title":"Navigating nomograms to identify prostate cancer patients for lymph node dissection","volume":"6","author":"Karakiewicz","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jamaoncol.2015.4350","article-title":"Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer","volume":"2","author":"James","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.01.004_b0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1702900","article-title":"Abiraterone for prostate cancer not previously treated with hormone therapy","volume":"377","author":"James","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.01.004_b0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euo.2023.08.010","article-title":"Which patients with prostate cancer and lymph node uptake at preoperative prostate-specific membrane antigen positron emission tomography\/computerized tomography scan are at a higher risk of prostate-specific antigen persistence after radical prostatectomy","volume":"7","author":"Mazzone","year":"2024","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:57:01Z","timestamp":1775681821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2588931125000045"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.01.004","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}